Skip to main content
Fig. 1 | Biomarker Research

Fig. 1

From: CAR-T cell therapy followed by allogenic hematopoietic stem cell transplantation yielded comparable outcome between Ph like ALL and other high-risk ALL

Fig. 1

a Treatment response of all Ph-like ALL patients. b OS of of Ph-like patients, which showed comparable OS of JAK-STAT activated and ABL1 class Ph-like ALL. c RFS of Ph-like patients, which showed comparable RFS of JAK-STAT activated and ABL1 class Ph-like ALL. d-f OS, RFS and CIR of all the patients, which showed comparable OS, RFS and CIR of Ph-like ALL with Ph+ALL and B-ALL-others

Back to article page